<?xml version="1.0" encoding="UTF-8"?>
<p>Particularly, aristolochic acid, an alkaloid from 
 <italic>Aristolochia clematitis</italic> L., showed immunostimulatory properties, by enhancing the phagocytic activity of peritoneal macrophages and leukocytes; however, its potential cannot be exploited, because of its carcinogenic risk [
 <xref rid="B50-vaccines-08-00468" ref-type="bibr">50</xref>]. Likewise, vincristine and staurosporine act as immunostimulants at low doses, while as immunosuppressors at higher doses [
 <xref rid="B51-vaccines-08-00468" ref-type="bibr">51</xref>]. Among polyphenols, resveratrol stimulated both cellular and humoral immunity in preclinical models, thus preventing pathogen replication and inflammation, and promoted antitumor immune response too [
 <xref rid="B52-vaccines-08-00468" ref-type="bibr">52</xref>]. Furthermore, cichoric acid from echinacea promoted phagocytic activity, both 
 <italic>in vitro</italic> and 
 <italic>in vivo</italic> [
 <xref rid="B53-vaccines-08-00468" ref-type="bibr">53</xref>]. Anti-inflammatory and immune-modulatory effects has been highlighted for curcumin too, although the poor bioavailability limits its clinical application [
 <xref rid="B54-vaccines-08-00468" ref-type="bibr">54</xref>].
</p>
